Alefacept promotes co-stimulation blockade based allograft survival in nonhuman primates - Wikidata - wikimedia - TriplyDB

Alefacept promotes co-stimulation blockade based allograft survival in nonhuman primates

Alefacept promotes co-stimulation blockade based allograft survival in nonhuman primates

http://www.wikidata.org/entity/Q34991139

about

Co-Stimulatory Blockade of the CD28/CD80-86/CTLA-4 Balance in Transplantation: Impact on Memory T Cells?Viewing transplantation immunology through today's lens: new models, new imaging, and new insights.Current state of renal transplant immunosuppression: Present and future Transplantation tolerance and its outcome during infections and inflammation Concordance of preclinical and clinical pharmacology and toxicology of therapeutic monoclonal antibodies and fusion proteins: cell surface targets The CD8 T-cell response during tolerance induction in liver transplantation The future direction and unmet needs of transplant immunosuppression.Central memory CD8+ T lymphocytes mediate lung allograft acceptance.Pathogen Stimulation History Impacts Donor-Specific CD8(+) T Cell Susceptibility to Costimulation/Integrin Blockade-Based Therapy Memory T-cell-specific therapeutics in organ transplantation.Regulatory dendritic cell infusion prolongs kidney allograft survival in nonhuman primates.T-cell co-stimulatory blockade in kidney transplantation: back to the bench Alefacept promotes immunosuppression-free renal allograft survival in nonhuman primates via depletion of recipient memory T cells.Gazing into a crystal ball to predict kidney transplant outcome.Neutralizing BAFF/APRIL with atacicept prevents early DSA formation and AMR development in T cell depletion induced nonhuman primate AMR model.Selective targeting of human alloresponsive CD8+ effector memory T cells based on CD2 expression.Costimulatory pathways in transplantation.Belatacept and sirolimus prolong nonhuman primate renal allograft survival without a requirement for memory T cell depletion.LFA-1-specific therapy prolongs allograft survival in rhesus macaques.The allo- and viral-specific immunosuppressive effect of belatacept, but not tacrolimus, attenuates with progressive T cell maturation GVHD after haploidentical transplantation: a novel, MHC-defined rhesus macaque model identifies CD28- CD8+ T cells as a reservoir of breakthrough T-cell proliferation during costimulation blockade and sirolimus-based immunosuppression Heterologous immunity triggered by a single, latent virus in Mus musculus: combined costimulation- and adhesion- blockade decrease rejection.Preclinical and clinical studies on the induction of renal allograft tolerance through transient mixed chimerism.Host alloreactive memory T cells influence tolerance to kidney allografts in nonhuman primates T cells in the control of organ-specific autoimmunity Heterogeneity within T Cell Memory: Implications for Transplant Tolerance Down-Regulation of Surface CD28 under Belatacept Treatment: An Escape Mechanism for Antigen-Reactive T-Cells Alternative immunomodulatory strategies for xenotransplantation: CD40/154 pathway-sparing regimens promote xenograft survival.Evidence for kidney rejection after combined bone marrow and renal transplantation despite ongoing whole-blood chimerism in rhesus macaques.Overcoming the memory barrier in tolerance induction: molecular mimicry and functional heterogeneity among pathogen-specific T-cell populations.Regulatory T cells exhibit decreased proliferation but enhanced suppression after pulsing with sirolimus.Nonhuman primate transplant models finally evolve: detailed immunogenetic analysis creates new models and strengthens the old.Belatacept and sirolimus prolong nonhuman primate islet allograft survival: adverse consequences of concomitant alefacept therapy Enhanced de novo alloantibody and antibody-mediated injury in rhesus macaques.Blocking MHC class II on human endothelium mitigates acute rejection Postdepletion Lymphocyte Reconstitution During Belatacept and Rapamycin Treatment in Kidney Transplant Recipients.Can We Repurpose FDA-Approved Alefacept to Diminish the HIV Reservoir?Roles of CD48 in regulating immunity and tolerance.CD57(+) CD4 T Cells Underlie Belatacept-Resistant Allograft Rejection Targeting regulatory T cells in the treatment of type 1 diabetes mellitus.

P2860

Q26796099-8AAF6E1A-717B-4C1C-93D5-DDB89965ED41 Q26824352-450777E2-C052-417E-B796-A16D4FB3DDFC Q26829789-6102C01A-60FD-417E-8AB7-4756F580D4C1 Q26829817-13F37699-A94E-4D98-A30F-3F47CD4DCFD3 Q26830569-1F88DABA-F911-45CC-BB77-8DA6246AC328 Q28079184-1B40B77F-187D-47BB-9E7F-F140571DCE68 Q30277037-C7FA9ADD-B901-4C61-9080-AB70E07F4902 Q30573064-233A02FE-C342-4CE0-9A87-D6B1E6FFC51F Q33636211-EA1B8F87-D4B4-46B3-BE31-667796A02B84 Q33708195-B79F8C48-3595-4EE2-BF17-CE5F114EBADA Q33804736-934ACBEA-A281-4049-9567-6D38980FA7A0 Q33873078-6726F2F9-C784-41F9-B676-9838F81C4714 Q33881015-B3D443C1-4C80-4DAF-B437-B1A326D48775 Q33882966-37953251-1B01-4808-B21C-F8F70F71A36D Q33891669-132A0AB9-7D6B-4250-8848-1779888597E6 Q34149246-D6C13988-C4C9-47F2-9A24-508040F9B47C Q34187594-D8837F99-B6E9-4288-9C0C-9CF370570BE6 Q34322116-6B5A2ABA-71BE-4877-AB60-7CC6239FED7E Q34364120-1ADBD06F-8669-428F-88FF-2C51468E59CA Q34400561-002DADD6-F39B-40E3-B39C-8DE7E674765D Q34450497-3A9FC4A0-A9D1-4B79-B6A8-60520416771E Q34937146-3948F7C2-DC73-4126-A39B-53083F654023 Q35149926-A9C532BC-B454-483A-BF05-F17D95305EF3 Q35680600-D115C72B-3C4E-4259-AE61-D0BC384134AF Q35836118-8574CFCC-EEBB-42A2-B0E3-B0475B775B8E Q35927610-33FF00F9-7C22-48A9-A12C-85501E1388A5 Q35937227-9D8AB10C-5E63-425F-B82C-9F2890BD7382 Q36069451-60BB023F-4080-4674-BBF5-5FC497EB052B Q36069536-E36CA50A-9B56-4FDF-95C4-859061E4337B Q36273291-D6ABC1B9-2FA0-467D-9697-8DF246DDBD81 Q36316613-355A3FB4-7833-4FF7-9D93-8A04E46DB422 Q36351343-017E985F-D8B1-4A51-ADFE-D7B972D90E8F Q36572728-FA1D9223-6EB4-45E1-B1B4-0E6F3BB418B1 Q36575860-3C6CF27E-BCC1-4D83-8DD0-6E3070B738F6 Q36588477-AC04B2E0-51C3-4C0B-9180-1D09EC019E2E Q36769110-416F3DEB-154C-4DD8-96F4-1FD24D716146 Q36827134-3D4EF21C-055B-486A-BFA9-C41E88696A43 Q36883146-2D32ACD6-1083-48AA-A7AB-3E9839F6C912 Q36901437-D7122825-991E-430B-BAF9-A9D9DA5320C2 Q37006155-4845F4C4-7C15-4AEF-A680-EF25A4AF6762

P2860

Alefacept promotes co-stimulation blockade based allograft survival in nonhuman primates

http://www.wikidata.org/entity/Q34991139

description

2009 nî lūn-bûn

@nan

2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Alefacept promotes co-stimulation blockade based allograft survival in nonhuman primates

@ast

Alefacept promotes co-stimulation blockade based allograft survival in nonhuman primates

@en

Alefacept promotes co-stimulation blockade based allograft survival in nonhuman primates

@nl

type

label

Alefacept promotes co-stimulation blockade based allograft survival in nonhuman primates

@ast

Alefacept promotes co-stimulation blockade based allograft survival in nonhuman primates

@en

Alefacept promotes co-stimulation blockade based allograft survival in nonhuman primates

@nl

prefLabel

Alefacept promotes co-stimulation blockade based allograft survival in nonhuman primates

@ast

Alefacept promotes co-stimulation blockade based allograft survival in nonhuman primates

@en

Alefacept promotes co-stimulation blockade based allograft survival in nonhuman primates

@nl

P1433

Q34991139-FF44DDE7-C30A-4E89-98FF-F46DE2A1490E

P1476

Q34991139-D1957E2C-E0EE-40C4-858B-7C457FF62551

P2093

Q34991139-030195A1-4FAB-46DB-A335-8E19DFC07C03

Q34991139-0A1F9755-5DFC-4BF6-929D-BC1ADE833724

Q34991139-0C64492D-7940-4AB3-9700-CDEB961CC519

Q34991139-23490494-E5FD-4ABB-B270-4AC7B58AF601

Q34991139-342F8BA5-844A-4F7D-A0C3-41B9B6FE7EED

Q34991139-35E26F82-5372-4D30-895B-11540E61BE86

Q34991139-71BC372C-9598-4825-A431-B2C2ED56EE84

Q34991139-752C80F9-5DC6-4942-BD54-6F8D521918E4

Q34991139-B919EDF6-4E15-491F-9F93-80839BAD45DF

Q34991139-D73DA6B4-DCCC-4552-9735-D30B8D947443

P2860

Q34991139-021209AA-BF05-4612-B256-6D771767FC9B

Q34991139-069BE26C-4AE1-4AEE-B5B6-5DC1A336D299

Q34991139-0AE84D87-4088-44B8-9BD5-13EC90A24091

Q34991139-31365AB2-C61D-40A3-B76F-38BF9146B425

Q34991139-5FE02E3B-35DC-4BA7-8915-AB44899D9585

Q34991139-686044FA-0648-414B-89C0-B3626F7971BA

Q34991139-890213FC-6AE9-4E21-9380-C768F66E5101

Q34991139-C8110C10-C2F7-4148-BFA7-8C4A4E95171E

Q34991139-CC17EAA3-70D2-45A3-951E-7E2D9B6495D0

Q34991139-E10073E3-E4C7-4626-89E7-87FD88D625CB

P2888

Q34991139-B1B06178-8E45-4620-A3A8-67034DFAC87C

P304

Q34991139-7B6EF882-B404-4DD5-98FF-B5CF3044BB83

P31

Q34991139-96198CBC-B22E-4E21-B97C-6C5EA98D5622

P356

Q34991139-497DF37C-A9DB-4343-96FE-F614021619D0

P407

Q34991139-1FBE67F1-36C7-47A1-B81C-AEEB1FBB9E43

P433

Q34991139-F61E227E-FE6A-4BD5-8336-3938D54046F9

P478

Q34991139-B3E28677-C615-4C03-B46F-9DB4F93156E1

P577

Q34991139-8CDBDC9C-8B7A-49D7-B9CC-43CEF41062F5

P5875

Q34991139-10EE52C2-8D71-41DC-81FE-EBD9FB70992F

P698

Q34991139-2E00AC84-E0E9-49BC-B98C-6C3FDDC55EE0

P932

Q34991139-56EF2F7D-F64A-4EF5-8E71-7E0A5CC46D77

P356

P1433

Nature Medicine

P1476

Alefacept promotes co-stimulation blockade based allograft survival in nonhuman primates

@en

P2093

Alexandra P Turner

http://www.w3.org/2001/XMLSchema#string

Ali H Charafeddine

http://www.w3.org/2001/XMLSchema#string

Allan D Kirk

http://www.w3.org/2001/XMLSchema#string

Avinash Agarwal

http://www.w3.org/2001/XMLSchema#string

Christian P Larsen

http://www.w3.org/2001/XMLSchema#string

Frank V Leopardi

http://www.w3.org/2001/XMLSchema#string

Linda Stempora

http://www.w3.org/2001/XMLSchema#string

Maria Russell

http://www.w3.org/2001/XMLSchema#string

Mingqing Song

http://www.w3.org/2001/XMLSchema#string

Robert L Kampen

http://www.w3.org/2001/XMLSchema#string

P2860

Homeostatic proliferation is a barrier to transplantation tolerance.

Alefacept reduces infiltrating T cells, activated dendritic cells, and inflammatory genes in psoriasis vulgaris

Heterologous immunity provides a potent barrier to transplantation tolerance

Crossing the bridge: large animal models in translational transplantation research.

Immunosuppression: evolution in practice and trends, 1994-2004.

Functional signatures of protective antiviral T-cell immunity in human virus infections.

Frontiers in nephrology: T cell memory as a barrier to transplant tolerance.

Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA4Ig plus donor-specific transfusion.

Development and homeostasis of T cell memory in rhesus macaque.

IDEC-131 (anti-CD154), sirolimus and donor-specific transfusion facilitate operational tolerance in non-human primates.

P2888

P304

746-749

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NM.1993

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2009-07-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26654325

http://www.w3.org/2001/XMLSchema#string

P698

19584865

http://www.w3.org/2001/XMLSchema#string

P932

2772128

http://www.w3.org/2001/XMLSchema#string